BC Guidelines are clinical practice guidelines and protocols that provide recommendations to B.C. practitioners on delivering high quality, appropriate care to patients with specific clinical conditions or diseases. These “Made in BC” clinical practice guidelines are developed by the Guidelines and Protocol Advisory Committee (GPAC), an advisory committee to the Medical Services Commission. The primary audience for BC Guidelines is BC physicians, nurse practitioners, and medical students. However, other audiences such as health educators, health authorities, allied health organizations, pharmacists, and nurses may also find them to be a useful resource.
There are several ways to find the guidelines you are looking for.
For information on COVID-19, visit the BC Centre for Disease Control website.
NOW AVAILABLE FOR EXTERNAL PEER REVIEW: Draft Stroke and Transient Ischemic Attack (TIA) Part One: Diagnosis and Acute Management
Review the draft guideline HERE and submit your feedback by June 27, 2025
REVISED: Chronic Obstructive Pulmonary Disease
Minor revisions to the Chronic Obstructive Pulmonary Disease (COPD) guideline to reflect new PharmaCare regular benefit coverage for Tiotropium.
NEW: Tobacco Use Disorder (TUD)
The Tobacco Use Disorder (TUD) guideline provides evidence-based recommendations for primary care practitioners on managing tobacco use disorder (TUD). This guideline also addresses vaping. While the guideline focuses on TUD in adults (ages ≥ 19), there are some recommendations addressing the youth population (ages 12-18).
Key Recommendations